ReWalk Receives CE Marking for its Stroke Rehabilitation Suit

Nasdaq-listed ReWalk Robotics Ltd., which develops wearable exoskeletons that help people walk again after injuries and strokes, has received European regulatory approval for its new exo-suit for stroke rehabilitation called “ReStore”, the company announced Thursday. The CE mark clears it for sale to rehabilitation clinics in the European Union.

Founded in 2001, ReWalk has two product lines. The first, a rigid-frame exoskeleton for people who cannot walk on their own due to spinal cord injuries, has been on the market for several years. ReStore, the company’s new product line, is a soft-frame suit meant for stroke victims learning to regain motor skills in their lower limbs. The suit uses software and mechanical mechanisms to prop up the lower body at key joints. Rewalk is based in Marlborough, Massachusetts and in Yokneam Illit, Israel, and has approximately 60 employees, according to Pitchbook.